Noel, Gary J.

Publications

Sort by

Co-Author Network

selected publications

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach. Journal of the Pediatric Infectious Diseases Society. 2019 Information Resource GET IT
Times cited: 4
Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators. Contemporary clinical trials communications. 2018 Academic Article GET IT
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative. Contemporary clinical trials communications. 2017 Academic Article GET IT
Times cited: 12
Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics. 2014 Academic Article GET IT
Times cited: 38
Children's medicines in Tanzania: a national survey of administration practices and preferences. PloS one. 2013 Academic Article GET IT
Times cited: 28
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy. 2012 Academic Article GET IT
Times cited: 75
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation. International journal of antimicrobial agents. 2012 Academic Article GET IT
Times cited: 80
Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children. Antimicrobial agents and chemotherapy. 2009 Academic Article GET IT
Times cited: 42
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy. 2009 Academic Article GET IT
Times cited: 13
Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole. Antimicrobial agents and chemotherapy. 2009 Academic Article GET IT
Times cited: 59
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy. 2008 Academic Article GET IT
Times cited: 11
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. The Pediatric infectious disease journal. 2008 Academic Article GET IT
Times cited: 25
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Academic Article GET IT
Times cited: 199
Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin. Antimicrobial agents and chemotherapy. 2007 Academic Article GET IT
Times cited: 5
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrobial agents and chemotherapy. 2007 Academic Article GET IT
Times cited: 174
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. The Pediatric infectious disease journal. 2007 Academic Article GET IT
Times cited: 79
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. The Pediatric infectious disease journal. 2007 Academic Article GET IT
Times cited: 58
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2007 Information Resource GET IT
Times cited: 44
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy. Expert opinion on investigational drugs. 2007 Information Resource GET IT
Times cited: 65
Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects. Antimicrobial agents and chemotherapy. 2007 Academic Article GET IT
Times cited: 69
An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. The Pediatric infectious disease journal. 2006 Academic Article GET IT
Times cited: 30
Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiology and drug safety. 2006 Academic Article GET IT
Times cited: 64
Levofloxacin pharmacokinetics in children. Journal of clinical pharmacology. 2005 Academic Article GET IT
Times cited: 59
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. Journal of clinical pharmacology. 2004 Academic Article GET IT
Times cited: 51
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrobial agents and chemotherapy. 2003 Academic Article GET IT
Times cited: 56
Effects of three fluoroquinolones on QT interval in healthy adults after single doses. Clinical pharmacology and therapeutics. 2003 Academic Article GET IT
Times cited: 135
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. The Journal of antimicrobial chemotherapy. 2002 Academic Article GET IT
Times cited: 61
Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. The Pediatric infectious disease journal. 2002 Academic Article GET IT
Times cited: 78
Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. Journal of clinical immunology. 2001 Academic Article GET IT
Times cited: 78
The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin. The Journal of antimicrobial chemotherapy. 2000 Academic Article GET IT
Times cited: 35
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children. The Pediatric infectious disease journal. 2000 Article GET IT
Times cited: 4
Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 48
Genotypic characterization of human immunodeficiency virus type 1 isolated from vertically infected children with antiretroviral therapy experience. The Pediatric infectious disease journal. 2000 Academic Article GET IT
Times cited: 9
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. The Journal of pediatrics. 1999 Academic Article GET IT
Times cited: 1
Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children. The Pediatric infectious disease journal. 1999 Academic Article GET IT
Times cited: 13
Neuroimaging findings in children perinatally infected with the human immunodeficiency virus. The Pediatric infectious disease journal. 1998 Academic Article GET IT
Times cited: 26
Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 276
An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center. The Pediatric infectious disease journal. 1998 Academic Article GET IT
Times cited: 25
Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s. The Pediatric infectious disease journal. 1997 Academic Article GET IT
Times cited: 31
Endogenous interleukin-2 serum levels in children infected with human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997 Academic Article GET IT
Times cited: 2
Selective suppression of interleukin-12 induction after macrophage receptor ligation. The Journal of experimental medicine. 1997 Academic Article GET IT
Times cited: 305
Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae. Infection and immunity. 1996 Academic Article GET IT
Times cited: 40
Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. The Pediatric infectious disease journal. 1996 Academic Article GET IT
Times cited: 51
High-molecular-weight proteins of nontypeable Haemophilus influenzae mediate bacterial adhesion to cellular proteoglycans. Infection and immunity. 1994 Academic Article GET IT
Times cited: 45
High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages. The Journal of infectious diseases. 1994 Academic Article GET IT
Times cited: 18
Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. The Pediatric infectious disease journal. 1993 Academic Article GET IT
Times cited: 19
Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. The Journal of infectious diseases. 1992 Academic Article GET IT
Times cited: 33
The role of complement and murine monoclonal antibodies in binding and ingestion of Haemophilus influenzae type b by murine macrophages. The Journal of infectious diseases. 1992 Academic Article GET IT
Times cited: 3
Multiple methicillin-resistant Staphylococcus aureus strains as a cause for a single outbreak of severe disease in hospitalized neonates. The Pediatric infectious disease journal. 1992 Academic Article GET IT
Times cited: 36
In vivo stability of heterogeneous expression classes in clinical isolates of methicillin-resistant staphylococci. The Journal of infectious diseases. 1991 Academic Article GET IT
Times cited: 36
The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophages. Pediatric research. 1991 Academic Article GET IT
Times cited: 16
Persistent bacteremia. Pediatrics. 1990 Article GET IT
Times cited: 1
Role of complement in mouse macrophage binding of Haemophilus influenzae type b. The Journal of clinical investigation. 1990 Academic Article GET IT
Times cited: 27
Resistance to serum bactericidal activity distinguishes Brazilian purpuric fever (BPF) case strains of Haemophilus influenzae biogroup aegyptius (H. aegyptius) from non-BPF strains. Brazilian Purpuric Fever Study Group. Journal of clinical microbiology. 1989 Academic Article GET IT
Times cited: 13
Anaerobic bacteremia in a neonatal intensive care unit: an eighteen-year experience. The Pediatric infectious disease journal. 1988 Academic Article GET IT
Times cited: 28
Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. The Journal of infectious diseases. 1988 Academic Article GET IT
Times cited: 24
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida. Antimicrobial agents and chemotherapy. 1986 Academic Article GET IT
Times cited: 26
Newborn sepsis following antepartum group B streptococcal maternal infection in rats. Pediatric research. 1985 Academic Article GET IT
Times cited: 3
Staphylococcus epidermidis bacteremia in neonates: further observations and the occurrence of focal infection. Pediatrics. 1984 Academic Article GET IT
Times cited: 77

more ...

less ...

Background

education and training

M.D., Cornell University Medical College 1980
A.B., Dartmouth College 1976

Contact

full name

Gary J. Noel

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Gary J. Noel Clinical Professor of Pediatrics (Courtesy)

Publications

selected publications

Background

education and training

Contact

full name

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

webpage